3003.10 | -Que contengan penicilinas o derivados de estos productos con la estructura del ácido penicilánico, o estreptomicinas o derivados de estos productos | | | | |
3003.10.1 | Que contengan penicilinas o derivados de estos productos con la estructura del ácido penicilánico | | | | |
3003.10.11 | Ampicilina o sus sales | | | | |
3003.10.11.000N | Ampicilina o sus sales | 12.6 | 0 | 0 | 5 |
3003.10.12 | Amoxicilina o sus sales | | | | |
3003.10.12.000W | Amoxicilina o sus sales | 7.2 | 0 | 0 | 5 |
3003.10.13 | Penicilina G benzatínica | | | | |
3003.10.13.000D | Penicilina G benzatínica | 12.6 | 0 | 0 | 5 |
3003.10.14 | Penicilina G potásica | | | | |
3003.10.14.000L | Penicilina G potásica | 7.2 | 0 | 0 | 5 |
3003.10.15 | Penicilina G procaínica | | | | |
3003.10.15.000U | Penicilina G procaínica | 7.2 | 0 | 0 | 5 |
3003.10.19 | Los demás | | | | |
3003.10.19.000Z | Los demás | 7.2 | 0 | 0 | 5 |
3003.10.20 | Que contengan estreptomicinas o derivados de estos productos | | | | |
3003.10.20.000Q | Que contengan estreptomicinas o derivados de estos productos | 7.2 | 0 | 0 | 5 |
3003.20 | -Los demás, que contengan antibióticos | | | | |
3003.20.1 | Que contengan anfenicoles o sus derivados | | | | |
3003.20.11 | Cloranfenicol, su palmitato, su succinato o su hemisuccinato | | | | |
3003.20.11.100H | Para medicina veterinaria (R.G. 2146/06 AFIP) | 7.2 | 0 | 0 | 5 |
3003.20.11.900B | Los demás | 7.2 | 0 | 0 | 5 |
3003.20.19 | Los demás | | | | |
3003.20.19.000N | Los demás | 7.2 | 0 | 0 | 5 |
3003.20.2 | Que contengan macrólidos o sus derivados | | | | |
3003.20.21 | Eritromicina o sus sales | | | | |
3003.20.21.000M | Eritromicina o sus sales | 12.6 | 0 | 0 | 5 |
3003.20.29 | Los demás | | | | |
3003.20.29.100D | Azitromicina o sus sales | 7.2 | 0 | 0 | 5 |
3003.20.29.200J | Roxitromicina o sus sales | 7.2 | 0 | 0 | 5 |
3003.20.29.900X | Los demás | 7.2 | 0 | 0 | 5 |
3003.20.3 | Que contengan ansamicinas o sus derivados | | | | |
3003.20.31 | Rifamicina SV sódica | | | | |
3003.20.31.000X | Rifamicina SV sódica | 7.2 | 0 | 0 | 5 |
3003.20.32 | Rifampicina | | | | |
3003.20.32.000E | Rifampicina | 7.2 | 0 | 0 | 5 |
3003.20.39 | Los demás | | | | |
3003.20.39.000H | Los demás | 7.2 | 0 | 0 | 5 |
3003.20.4 | Que contengan lincosamidas o sus derivados | | | | |
3003.20.41 | Clorhidrato de lincomicina | | | | |
3003.20.41.000G | Clorhidrato de lincomicina | 12.6 | 0 | 0 | 5 |
3003.20.49 | Los demás | | | | |
3003.20.49.000T | Los demás | 7.2 | 0 | 0 | 5 |
3003.20.5 | Que contengan cefalosporinas, cefamicinas o derivados de estos productos | | | | |
3003.20.51 | Cefalotina sódica | | | | |
3003.20.51.000R | Cefalotina sódica | 12.6 | 0 | 0 | 5 |
3003.20.52 | Cefaclor o cefalexina monohidratados | | | | |
3003.20.52.100E | Cefaclor monohidratado | 12.6 | 0 | 0 | 5 |
3003.20.52.200K | Cefalexina monohidratada | 12.6 | 0 | 0 | 5 |
3003.20.59 | Los demás | | | | |
3003.20.59.100H | Cefalotina o sus sales, excepto la sal sódica | 7.2 | 0 | 0 | 5 |
3003.20.59.200N | Cefazolina o sus sales | 7.2 | 0 | 0 | 5 |
3003.20.59.900B | Los demás | 7.2 | 0 | 0 | 5 |
3003.20.6 | Que contengan aminoglicósidos o sus derivados | | | | |
3003.20.61 | Sulfato de gentamicina | | | | |
3003.20.61.000B | Sulfato de gentamicina | 12.6 | 0 | 0 | 5 |
3003.20.62 | Daunorubicina | | | | |
3003.20.62.000J | Daunorubicina | 0 | 0 | 0 | 5 |
3003.20.63 | Idarubicina; pirarubicina | | | | |
3003.20.63.000R | Idarubicina; pirarubicina | 0 | 0 | 0 | 5 |
3003.20.69 | Los demás | | | | |
3003.20.69.000M | Los demás | 7.2 | 0 | 0 | 5 |
3003.20.7 | Que contengan polipeptidos o sus derivados | | | | |
3003.20.71 | Vancomicina | | | | |
3003.20.71.000L | Vancomicina | 7.2 | 0 | 0 | 5 |
3003.20.72 | Actinomicinas | | | | |
3003.20.72.000U | Actinomicinas | 0 | 0 | 0 | 5 |
3003.20.73 | Ciclosporina A | | | | |
3003.20.73.000B | Ciclosporina A | 0 | 0 | 0 | 5 |
3003.20.79 | Los demás | | | | |
3003.20.79.000X | Los demás | 7.2 | 0 | 0 | 5 |
3003.20.9 | Los demás | | | | |
3003.20.91 | Mitomicina | | | | |
3003.20.91.000F | Mitomicina | 0 | 0 | 0 | 5 |
3003.20.92 | Fumarato de tiamulina | | | | |
3003.20.92.000N | Fumarato de tiamulina | 7.2 | 0 | 0 | 5 |
3003.20.93 | Bleomicinas o sus sales | | | | |
3003.20.93.000W | Bleomicinas o sus sales | 0 | 0 | 0 | 5 |
3003.20.94 | Imipenem | | | | |
3003.20.94.000D | Imipenem | 0 | 0 | 0 | 5 |
3003.20.95 | Anfotericina B en liposomas | | | | |
3003.20.95.000L | Anfotericina B en liposomas | 0 | 0 | 0 | 5 |
3003.20.99 | Los demás | | | | |
3003.20.99.000R | Los demás | 7.2 | 0 | 0 | 5 |
3003.3 | -Los demás, que contengan hormonas u otros productos de la partida 29.37: | | | | |
3003.31.00 | —Que contengan insulina | | | | |
3003.31.00.000L | —Que contengan insulina | 12.6 | 0 | 0 | 5 |
3003.39 | —Los demás | | | | |
3003.39.1 | Que contengan las siguientes hormonas polipeptídicas o proteicas: buserelina o su acetato; corticotropina (ACTH); gonadotropina coriónica (hCG); gonadotropina serica (PMSG); leuprolide o su acetato; menotropinas; somatostatina o sus sales; somatotropina; triptorelina o sus sales | | | | |
3003.39.11 | Somatotropina | | | | |
3003.39.11.000Z | Somatotropina | 0 | 0 | 0 | 5 |
3003.39.12 | Gonadotropina coriónica (hCG) | | | | |
3003.39.12.000G | Gonadotropina coriónica (hCG) | 12.6 | 0 | 0 | 5 |
3003.39.13 | Menotropinas | | | | |
3003.39.13.000P | Menotropinas | 12.6 | 0 | 0 | 5 |
3003.39.14 | Corticotropina (ACTH) | | | | |
3003.39.14.000X | Corticotropina (ACTH) | 7.2 | 0 | 0 | 5 |
3003.39.15 | Gonadotropina serica (PMSG) | | | | |
3003.39.15.000E | Gonadotropina serica (PMSG) | 7.2 | 0 | 0 | 5 |
3003.39.16 | Somatostatina o sus sales | | | | |
3003.39.16.000M | Somatostatina o sus sales | 0 | 0 | 0 | 5 |
3003.39.17 | Buserelina o su acetato | | | | |
3003.39.17.000V | Buserelina o su acetato | 0 | 0 | 0 | 5 |
3003.39.18 | Triptorelina o sus sales | | | | |
3003.39.18.000C | Triptorelina o sus sales | 0 | 0 | 0 | 5 |
3003.39.19 | Leuprolide o su acetato | | | | |
3003.39.19.000K | Leuprolide o su acetato | 0 | 0 | 0 | 5 |
3003.39.2 | Que contengan las demás hormonas polipeptídicas o proteicas, sus derivados o análogos estructurales, sin productos de la subpartida 3003.39.1 | | | | |
3003.39.21 | LH-RH (gonadorelina) | | | | |
3003.39.21.000J | LH-RH (gonadorelina) | 0 | 0 | 0 | 5 |
3003.39.22 | Oxitocina | | | | |
3003.39.22.000R | Oxitocina | 12.6 | 0 | 0 | 5 |
3003.39.23 | Sales de insulina | | | | |
3003.39.23.000Z | Sales de insulina | 12.6 | 0 | 0 | 5 |
3003.39.24 | Timosinas | | | | |
3003.39.24.000G | Timosinas | 0 | 0 | 0 | 5 |
3003.39.25 | Octreotida | | | | |
3003.39.25.000P | Octreotida | 0 | 0 | 0 | 5 |
3003.39.26 | Goserelina o su acetato | | | | |
3003.39.26.000X | Goserelina o su acetato | 0 | 0 | 0 | 5 |
3003.39.27 | Nafarelina o su acetato | | | | |
3003.39.27.000E | Nafarelina o su acetato | 0 | 0 | 0 | 5 |
3003.39.29 | Los demás | | | | |
3003.39.29.000V | Los demás | 7.2 | 0 | 0 | 5 |
3003.39.3 | Que contengan estrógenos o progestógenos, sus derivados o análogos estructurales | | | | |
3003.39.31 | Hemisuccinato de estradiol | | | | |
3003.39.31.000U | Hemisuccinato de estradiol | 12.6 | 0 | 0 | 5 |
3003.39.32 | Fempropionato de estradiol | | | | |
3003.39.32.000B | Fempropionato de estradiol | 12.6 | 0 | 0 | 5 |
3003.39.33 | Estriol o su succinato | | | | |
3003.39.33.000J | Estriol o su succinato | 12.6 | 0 | 0 | 5 |
3003.39.34 | Alilestrenol | | | | |
3003.39.34.000R | Alilestrenol | 12.6 | 0 | 0 | 5 |
3003.39.35 | Linestrenol | | | | |
3003.39.35.000Z | Linestrenol | 12.6 | 0 | 0 | 5 |
3003.39.36 | Acetato de megestrol; formestano, fulvestrant | | | | |
3003.39.36.100M | Acetato de megestrol | 0 | 0 | 0 | 5 |
3003.39.36.200T | Formestano | 0 | 0 | 0 | 5 |
3003.39.36.300Y | Fulvestrant | 0 | 0 | 0 | 5 |
3003.39.37 | Desogestrel | | | | |
3003.39.37.000P | Desogestrel | 12.6 | 0 | 0 | 5 |
3003.39.39 | Los demás | | | | |
3003.39.39.000E | Los demás | 7.2 | 0 | 0 | 5 |
3003.39.8 | Levotiroxina sódica; liotironina sódica | | | | |
3003.39.81 | Levotiroxina sódica | | | | |
3003.39.81.000T | Levotiroxina sódica | 10.8 | 0 | 0 | 5 |
3003.39.82 | Liotironina sódica | | | | |
3003.39.82.000A | Liotironina sódica | 10.8 | 0 | 0 | 5 |
3003.39.9 | Los demás | | | | |
3003.39.91 | Sal sódica o ester met?lico del ácido 9,11,15-trihidroxi-16-(3-clorofenoxi) prosta-5,13-dien-1-oico (derivado de la prostaglandina F2-alfa) | | | | |
3003.39.91.000C | Sal sódica o ester met?lico del ácido 9,11,15-trihidroxi-16-(3-clorofenoxi) prosta-5,13-dien-1-oico (derivado de la prostaglandina F2-alfa) | 0 | 0 | 0 | 5 |
3003.39.92 | Tiratricol(triac) o su sal sódica | | | | |
3003.39.92.000K | Tiratricol(triac) o su sal sódica | 12.6 | 0 | 0 | 5 |
3003.39.94 | Espironolactona | | | | |
3003.39.94.000A | Espironolactona | 12.6 | 0 | 0 | 5 |
3003.39.95 | Exemestano | | | | |
3003.39.95.000H | Exemestano | 0 | 0 | 0 | 5 |
3003.39.99 | Los demás | | | | |
3003.39.99.000N | Los demás | 7.2 | 0 | 0 | 5 |
3003.4 | -Los demás, que contengan alcaloides o sus derivados: | | | | |
3003.41.00 | —Que contengan efedrina o sus sales | | | | |
3003.41.00.000A | —Que contengan efedrina o sus sales | 7.2 | 0 | 0 | 5 |
3003.42.00 | —Que contengan seudoefedrina (DCI) o sus sales | | | | |
3003.42.00.000M | —Que contengan seudoefedrina (DCI) o sus sales | 7.2 | 0 | 0 | 5 |
3003.43.00 | —Que contengan norefedrina o sus sales | | | | |
3003.43.00.000Z | —Que contengan norefedrina o sus sales | 7.2 | 0 | 0 | 5 |
3003.49 | —Los demás | | | | |
3003.49.10 | Vimblastina; vincristina; derivados de estos productos; topotecan o su clorhidrato | | | | |
3003.49.10.000F | Vimblastina; vincristina; derivados de estos productos; topotecan o su clorhidrato | 0 | 0 | 0 | 5 |
3003.49.20 | Pilocarpina, su nitrato o su clorhidrato | | | | |
3003.49.20.000Q | Pilocarpina, su nitrato o su clorhidrato | 12.6 | 0 | 0 | 5 |
3003.49.30 | Metansulfonato de dihidroergocristina | | | | |
3003.49.30.000A | Metansulfonato de dihidroergocristina | 7.2 | 0 | 0 | 5 |
3003.49.40 | Codeína o sus sales | | | | |
3003.49.40.000K | Codeína o sus sales | 12.6 | 0 | 0 | 5 |
3003.49.50 | Granisetrón; tropisetrón o su clorhidrato | | | | |
3003.49.50.000V | Granisetrón; tropisetrón o su clorhidrato | 0 | 0 | 0 | 5 |
3003.49.90 | Los demás | | | | |
3003.49.90.1 | Que contengan sicotropos Lista I (R.2017/93 ex-ANA) | | | | |
3003.49.90.11 | Lisergida; DET; DMT; ibogaína; mescalina; psilocibina; psilocina; marmalina; marmina | | | | |
3003.49.90.111V | Lisergida | 7.2 | 0 | 0 | 5 |
3003.49.90.112X | DET | 7.2 | 0 | 0 | 5 |
3003.49.90.113Z | DMT | 7.2 | 0 | 0 | 5 |
3003.49.90.114B | Iboga?na | 7.2 | 0 | 0 | 5 |
3003.49.90.115D | Mescalina | 7.2 | 0 | 0 | 5 |
3003.49.90.116F | Psilocibina | 7.2 | 0 | 0 | 5 |
3003.49.90.117H | Psilocina | 7.2 | 0 | 0 | 5 |
3003.49.90.118K | Marmalina | 7.2 | 0 | 0 | 5 |
3003.49.90.119M | Marmina | 7.2 | 0 | 0 | 5 |
3003.49.90.190U | Los demás | 7.2 | 0 | 0 | 5 |
3003.49.90.2 | Que contengan otros sicotropos (R.2017/93 ex-ANA) | | | | |
3003.49.90.210Y | Metanfetamina | 7.2 | 0 | 0 | 5 |
3003.49.90.220B | Buprenorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.230E | Catina | 7.2 | 0 | 0 | 5 |
3003.49.90.240H | Fenetilina | 7.2 | 0 | 0 | 5 |
3003.49.90.290Z | Los demás | 7.2 | 0 | 0 | 5 |
3003.49.90.3 | Que contengan estupefacientes Lista IV (R.2017/93 ex-ANA) | | | | |
3003.49.90.310D | Heroína | 7.2 | 0 | 0 | 5 |
3003.49.90.320G | Desomorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.330K | Acetorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.340N | Etorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.350R | Nalline o nalorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.390E | Los demás | 7.2 | 0 | 0 | 5 |
3003.49.90.4 | Que contengan otros estupefacientes (R.2017/93 ex-ANA) | | | | |
3003.49.90.41 | Hidrocodona y sus esteres; oxicodona; bencilmorfina; codoxima; dihidromorfina y sus esteres;hidromorfinol; hidromorfona y su esteres | | | | |
3003.49.90.411L | Hidrocodona | 7.2 | 0 | 0 | 5 |
3003.49.90.412N | Oxicodona | 7.2 | 0 | 0 | 5 |
3003.49.90.413Q | Bencilmorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.414T | Codoxima | 7.2 | 0 | 0 | 5 |
3003.49.90.415V | Esteres de dihidromorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.416X | Dihidromorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.417Z | Esteres de la hidrocodona | 7.2 | 0 | 0 | 5 |
3003.49.90.418B | Hidromorfinol | 7.2 | 0 | 0 | 5 |
3003.49.90.419D | Hidromorfona y sus esteres | 7.2 | 0 | 0 | 5 |
3003.49.90.42 | Metildesorfina; metildihidromorfina; metopon; mirofina; morfina y sus sales; bromometilato de morfina y otros derivados de la morfina; N-oximorfina incluida la N-oxicodeína | | | | |
3003.49.90.421P | Metildesorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.422R | Metildihidromorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.423U | Metopon | 7.2 | 0 | 0 | 5 |
3003.49.90.424W | Mirofina | 7.2 | 0 | 0 | 5 |
3003.49.90.425Y | Morfina | 7.2 | 0 | 0 | 5 |
3003.49.90.426A | Sales de la morfina | 7.2 | 0 | 0 | 5 |
3003.49.90.427C | Bromometilato de morfina y otros derivados de la morfina | 7.2 | 0 | 0 | 5 |
3003.49.90.428E | N-Oximorfina incluida la N-oxicode?na | 7.2 | 0 | 0 | 5 |
3003.49.90.43 | Derivados de la N-oximorfina; nicomorfina; normorfina; ésteres de la oxicodona; oximorfona; tebacon;tebaína; cocaína | | | | |
3003.49.90.431T | Derivados de la N-oximorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.432V | Nicomorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.433X | Normorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.434Z | Esteres de la oxicodona | 7.2 | 0 | 0 | 5 |
3003.49.90.435B | Oximorfona | 7.2 | 0 | 0 | 5 |
3003.49.90.436D | Tebacon | 7.2 | 0 | 0 | 5 |
3003.49.90.437F | Tebaína | 7.2 | 0 | 0 | 5 |
3003.49.90.438H | Cocaína | 7.2 | 0 | 0 | 5 |
3003.49.90.44 | Ecgonina y sus ésteres; etilmorfina; folcodina; acetildihidrocodeína; dihidrocodeína; nicocodina; nicodicodina | | | | |
3003.49.90.441W | Ecgonina | 7.2 | 0 | 0 | 5 |
3003.49.90.442Y | Esteres de la ecgonina | 7.2 | 0 | 0 | 5 |
3003.49.90.444C | Etilmorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.445E | Folcodina | 7.2 | 0 | 0 | 5 |
3003.49.90.446G | Acetildihidrocodeina | 7.2 | 0 | 0 | 5 |
3003.49.90.447J | Dihidrocodeína | 7.2 | 0 | 0 | 5 |
3003.49.90.448L | Nicocodina | 7.2 | 0 | 0 | 5 |
3003.49.90.449N | Nicodicodina | 7.2 | 0 | 0 | 5 |
3003.49.90.45 | Norcodeína; dehidroetorfina | | | | |
3003.49.90.451Z | Norcode?na | 7.2 | 0 | 0 | 5 |
3003.49.90.452B | Dehidroetorfina | 7.2 | 0 | 0 | 5 |
3003.49.90.490K | Los demás | 7.2 | 0 | 0 | 5 |
3003.49.90.500L | Isómeros ópticos o sales de los isómeros ópticos de la efedrina | 7.2 | 0 | 0 | 5 |
3003.49.90.600R | Isómeros ópticos o sales de los isómeros ópticos de la seudoefedrina | 7.2 | 0 | 0 | 5 |
3003.49.90.700X | Isómeros ópticos o sales de los isómeros ópticos de la norefedrina | 7.2 | 0 | 0 | 5 |
3003.49.90.900H | Los demás | 7.2 | 0 | 0 | 5 |
3003.60.00 | -Los demás, que contengan los principios activos contra la malaria (paludismo)descritos en la Nota 2 de subpartida del presente Capítulo | | | | |
3003.60.00.000R | -Los demás, que contengan los principios activos contra la malaria (paludismo)descritos en la Nota 2 de subpartida del presente Capítulo | 7.2 | 0 | 0 | 5 |
3003.90 | -Los demás | | | | |
3003.90.1 | Que contengan vitaminas u otros productos de la partida 29.36 | | | | |
3003.90.11 | Folinato de calcio (leucovorina) | | | | |
3003.90.11.000B | Folinato de calcio (leucovorina) | 7.2 | 0 | 0 | 5 |
3003.90.12 | Nicotinamida | | | | |
3003.90.12.000J | Nicotinamida | 12.6 | 0 | 0 | 5 |
3003.90.13 | Hidroxocobalamina o sus sales; cianocobalamina | | | | |
3003.90.13.100X | Hidroxocobalamina o sus sales | 12.6 | 0 | 0 | 5 |
3003.90.13.200C | Cianocobalamina | 12.6 | 0 | 0 | 5 |
3003.90.14 | Vitamina A1 (retinol) o sus derivados, excepto el ácido retinoico (tretinoína) | | | | |
3003.90.14.000Z | Vitamina A1 (retinol) o sus derivados, excepto el ácido retinoico (tretinoína) | 12.6 | 0 | 0 | 5 |
3003.90.15 | D-Pantotenato de calcio; vitamina D3 (colecalciferol) | | | | |
3003.90.15.100M | D-Pantotenato de calcio | 7.2 | 0 | 0 | 5 |
3003.90.15.200T | Vitamina D3 (colecalciferol) | 7.2 | 0 | 0 | 5 |
3003.90.16 | Esteres de las vitaminas A y D3, en concentración superior o igual a 1.500.000 UI/g de vitamina A y superior o igual a 50.000 UI/g de vitamina D3 | | | | |
3003.90.16.000P | Esteres de las vitaminas A y D3, en concentración superior o igual a 1.500.000 UI/g de vitamina A y superior o igual a 50.000 UI/g de vitamina D3 | 7.2 | 0 | 0 | 5 |
3003.90.17 | Ácido retinoico (tretinoína) | | | | |
3003.90.17.000X | Ácido retinoico (tretinoína) | 7.2 | 0 | 0 | 5 |
3003.90.19 | Los demás | | | | |
3003.90.19.000M | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.2 | Que contengan enzimas, sin vitaminas ni otros productos de la partida 29.36 | | | | |
3003.90.21 | Estreptoquinasa | | | | |
3003.90.21.000L | Estreptoquinasa | 0 | 0 | 0 | 5 |
3003.90.22 | L-Asparaginasa | | | | |
3003.90.22.000U | L-Asparaginasa | 0 | 0 | 0 | 5 |
3003.90.23 | Deoxirribonucleasa | | | | |
3003.90.23.000B | Deoxirribonucleasa | 0 | 0 | 0 | 5 |
3003.90.24 | Idursulfasa | | | | |
3003.90.24.000J | Idursulfasa | 0 | 0 | 0 | 5 |
3003.90.25 | Agalsidasa alfa; velaglucerasa alfa | | | | |
3003.90.25.100X | Agalsidasa alfa | 0 | 0 | 0 | 5 |
3003.90.25.200C | Velaglucerasa alfa | 0 | 0 | 0 | 5 |
3003.90.29 | Los demás | | | | |
3003.90.29.000X | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.3 | Que contengan productos de las partidas 29.16 a 29.20, sin productos de las subpartidas 3003.90.1 y 3003.90.2 | | | | |
3003.90.31 | Permetrina; nitrato de propatilo; benzoato de bencilo; dioctilsulfosuccinato de sodio | | | | |
3003.90.31.100B | Permetrina | 12.6 | 0 | 0 | 5 |
3003.90.31.200G | Nitrato de propatilo | 12.6 | 0 | 0 | 5 |
3003.90.31.300M | Benzoato de bencilo | 12.6 | 0 | 0 | 5 |
3003.90.31.400T | Dioctilsulfosuccinato de sodio | 12.6 | 0 | 0 | 5 |
3003.90.32 | Ácido cólico; ácido deoxicólico; sal magnesica del ácido dehidrocólico | | | | |
3003.90.32.200P | Ácido cólico | 12.6 | 0 | 0 | 5 |
3003.90.32.300V | Ácido deoxicólico | 12.6 | 0 | 0 | 5 |
3003.90.32.400A | Sal magnesica del ácido dehidrocólico | 12.6 | 0 | 0 | 5 |
3003.90.33 | Ácido glucónico, sus sales o sus esteres | | | | |
3003.90.33.000L | Ácido glucónico, sus sales o sus esteres | 12.6 | 0 | 0 | 5 |
3003.90.34 | Ácido o-acetilsalicílico; o-acetilsalicilato de aluminio; salicilato de metilo; diclorvós | | | | |
3003.90.34.100Z | Acido o-acetilsalicilico | 12.6 | 0 | 0 | 5 |
3003.90.34.200E | o-Acetilsalicilato de aluminio | 12.6 | 0 | 0 | 5 |
3003.90.34.300K | Salicilato de metilo | 12.6 | 0 | 0 | 5 |
3003.90.34.400Q | Diclorvós | 12.6 | 0 | 0 | 5 |
3003.90.35 | Lactofosfato de calcio | | | | |
3003.90.35.000B | Lactofosfato de calcio | 12.6 | 0 | 0 | 5 |
3003.90.36 | Ácido láctico, sus sales o sus esteres; ácido 4-(4-hidroxifenoxi)-3,5- diiodofenilacético | | | | |
3003.90.36.100P | Acido láctico, sus sales o sus esteres | 12.6 | 0 | 0 | 5 |
3003.90.36.200V | Acido 4-(4-hidroxifenoxi)-3,5- diiodofenilacetico | 12.6 | 0 | 0 | 5 |
3003.90.37 | Ácido fumárico, sus sales o sus esteres | | | | |
3003.90.37.000R | Ácido fumárico, sus sales o sus esteres | 12.6 | 0 | 0 | 5 |
3003.90.38 | Etretinato; fosfestrol o sus sales de di o tetrasodio | | | | |
3003.90.38.200K | Etretinato | 0 | 0 | 0 | 5 |
3003.90.38.400W | Fosfestrol o sus sales de di o tetrasodio | 0 | 0 | 0 | 5 |
3003.90.39 | Los demás | | | | |
3003.90.39.1 | Que contengan difosfato o disulfato de dietilestilbestrol, o difosfato de hexestrol | | | | |
3003.90.39.110Q | Destinado a medicina veterinaria (R.2507/93 ex-ANA) | 7.2 | 0 | 0 | 5 |
3003.90.39.190R | Los demás (R.2014/93 ex-ANA) | 7.2 | 0 | 0 | 5 |
3003.90.39.2 | Que contengan estupefacientes (R. 2017 ex-ANA) | | | | |
3003.90.39.210W | Estupefacientes Lista IV | 7.2 | 0 | 0 | 5 |
3003.90.39.290X | Otros estupefacientes | 7.2 | 0 | 0 | 5 |
3003.90.39.3 | Que contengan sicotropos (R. 2017 ex-ANA) | | | | |
3003.90.39.310B | Sicotropos Lista I | 7.2 | 0 | 0 | 5 |
3003.90.39.390C | Otros sicotropos | 7.2 | 0 | 0 | 5 |
3003.90.39.900F | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.4 | Que contengan productos de las partidas 29.21 y 29.22, sin productos de las subpartidas 3003.90.1 a 3003.90.3 | | | | |
3003.90.41 | Sulfato de tranilcipromina; dietilpropión | | | | |
3003.90.41.100L | Sulfato de tranilcipromina | 12.6 | 0 | 0 | 5 |
3003.90.41.200R | Dietilpropión | 12.6 | 0 | 0 | 5 |
3003.90.42 | Clorhidrato de ketamina | | | | |
3003.90.42.000N | Clorhidrato de ketamina | 12.6 | 0 | 0 | 5 |
3003.90.43 | Clembuterol o su clorhidrato | | | | |
3003.90.43.000W | Clembuterol o su clorhidrato | 12.6 | 0 | 0 | 5 |
3003.90.44 | Tamoxifeno o su citrato | | | | |
3003.90.44.000D | Tamoxifeno o su citrato | 12.6 | 0 | 0 | 5 |
3003.90.45 | Levodopa; alfa-metildopa | | | | |
3003.90.45.100R | Levodopa | 12.6 | 0 | 0 | 5 |
3003.90.45.200X | alfa-Metildopa | 12.6 | 0 | 0 | 5 |
3003.90.46 | Clorhidrato de fenilefrina; mirtecaína; propanolol o sus sales | | | | |
3003.90.46.100Z | Clorhidrato de fenilefrina | 12.6 | 0 | 0 | 5 |
3003.90.46.200E | Mirtecaína | 12.6 | 0 | 0 | 5 |
3003.90.46.300K | Propanolol o sus sales | 12.6 | 0 | 0 | 5 |
3003.90.47 | Diclofenac sódico; diclofenac potásico; diclofenac dietilamina | | | | |
3003.90.47.100G | Diclofenac sódico | 12.6 | 0 | 0 | 5 |
3003.90.47.200M | Diclofenac potásico | 12.6 | 0 | 0 | 5 |
3003.90.47.300T | Diclofenac dietilamina | 12.6 | 0 | 0 | 5 |
3003.90.48 | Clorambucil; clormetina (DCI) o su clorhidrato; melfalano; toremifene o su citrato | | | | |
3003.90.48.100P | Melfalano | 0 | 0 | 0 | 5 |
3003.90.48.200V | Clorambucil | 0 | 0 | 0 | 5 |
3003.90.48.300A | Toremifene o su citrato | 0 | 0 | 0 | 5 |
3003.90.48.400F | Clormetina (DCI) o su clorhidrato | 0 | 0 | 0 | 5 |
3003.90.49 | Los demás | | | | |
3003.90.49.1 | Que contengan sicotropos Lista I (R.2017/93 ex-ANA) | | | | |
3003.90.49.110A | PCE | 7.2 | 0 | 0 | 5 |
3003.90.49.120D | PMA | 7.2 | 0 | 0 | 5 |
3003.90.49.130G | DMA | 7.2 | 0 | 0 | 5 |
3003.90.49.140K | DOB | 7.2 | 0 | 0 | 5 |
3003.90.49.150N | DOET | 7.2 | 0 | 0 | 5 |
3003.90.49.160R | STP o DOM | 7.2 | 0 | 0 | 5 |
3003.90.49.170V | TMA | 7.2 | 0 | 0 | 5 |
3003.90.49.190B | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.49.2 | Que contengan otros sicotropos (R. 2017/93 ex-ANA) | | | | |
3003.90.49.21 | Anfetamina; bencedrina; benzfetamina; clobenzorex; clorfentermina; dexanfetamina; fencanfamina; fentermina; levanfetamina | | | | |
3003.90.49.211H | Anfetamina | 7.2 | 0 | 0 | 5 |
3003.90.49.212K | Bencedrina | 7.2 | 0 | 0 | 5 |
3003.90.49.213M | Benzfetamina | 7.2 | 0 | 0 | 5 |
3003.90.49.214P | Clobenzorex | 7.2 | 0 | 0 | 5 |
3003.90.49.215R | Clorfentermina | 7.2 | 0 | 0 | 5 |
3003.90.49.216U | Dexanfetamina | 7.2 | 0 | 0 | 5 |
3003.90.49.217W | Fencanfamina | 7.2 | 0 | 0 | 5 |
3003.90.49.218Y | Fentermina | 7.2 | 0 | 0 | 5 |
3003.90.49.219A | Levanfetamina | 7.2 | 0 | 0 | 5 |
3003.90.49.22 | Mefenorex; N-etilanfetamina; anfepramona; metanfepramona; propilhexedrina; amitriptilina; clorhidrato de amitriptilina; benzoctamina; butiltriptilina | | | | |
3003.90.49.221L | Mefenorex | 7.2 | 0 | 0 | 5 |
3003.90.49.222N | N-Etilanfetamina | 7.2 | 0 | 0 | 5 |
3003.90.49.223Q | Anfepramona | 7.2 | 0 | 0 | 5 |
3003.90.49.224T | Metanfepramona | 7.2 | 0 | 0 | 5 |
3003.90.49.225V | Propilhexedrina | 7.2 | 0 | 0 | 5 |
3003.90.49.226X | Amitriptilina | 7.2 | 0 | 0 | 5 |
3003.90.49.227Z | Clorhidrato de amitriptilina | 7.2 | 0 | 0 | 5 |
3003.90.49.228B | Benzoctamina | 7.2 | 0 | 0 | 5 |
3003.90.49.229D | Butiltriptilina | 7.2 | 0 | 0 | 5 |
3003.90.49.23 | Maprotilina; nortriptilina; pargilina; protriptilina; SPA; fenfluramina; tranilcipromina; ciprodenato; demanyl fosfato | | | | |
3003.90.49.231P | Maprotilina | 7.2 | 0 | 0 | 5 |
3003.90.49.232R | Nortriptilina | 7.2 | 0 | 0 | 5 |
3003.90.49.233U | Pargilina | 7.2 | 0 | 0 | 5 |
3003.90.49.234W | Protriptilina | 7.2 | 0 | 0 | 5 |
3003.90.49.235Y | SPA | 7.2 | 0 | 0 | 5 |
3003.90.49.236A | Fenfluramina | 7.2 | 0 | 0 | 5 |
3003.90.49.237C | Tranilcipromina | 7.2 | 0 | 0 | 5 |
3003.90.49.238E | Ciprodenato | 7.2 | 0 | 0 | 5 |
3003.90.49.239G | Demanyl fosfato | 7.2 | 0 | 0 | 5 |
3003.90.49.240Q | Dimetilaminoetanol | 7.2 | 0 | 0 | 5 |
3003.90.49.250U | Clorhidrato de benactizina | 7.2 | 0 | 0 | 5 |
3003.90.49.260X | Centrofenoxina | 7.2 | 0 | 0 | 5 |
3003.90.49.290G | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.49.3 | Que contengan estupefacientes (R.2017/93 ex-ANA) | | | | |
3003.90.49.31 | Acetilmetadol; alfa-acetilmetadol; alfa-metadol; beta-acetilmetadol; beta-metadol; dimetileptanol; dimenoxadol; noracimetadol; isometadona | | | | |
3003.90.49.311N | Acetilmetadol | 7.2 | 0 | 0 | 5 |
3003.90.49.312Q | alfa-Acetilmetadol | 7.2 | 0 | 0 | 5 |
3003.90.49.313T | alfa-Metadol | 7.2 | 0 | 0 | 5 |
3003.90.49.314V | beta-Acetilmetadol | 7.2 | 0 | 0 | 5 |
3003.90.49.315X | beta-Metadol | 7.2 | 0 | 0 | 5 |
3003.90.49.316Z | Dimetileptanol | 7.2 | 0 | 0 | 5 |
3003.90.49.317B | Dimenoxadol | 7.2 | 0 | 0 | 5 |
3003.90.49.318D | Noracimetadol | 7.2 | 0 | 0 | 5 |
3003.90.49.319F | Isometadona | 7.2 | 0 | 0 | 5 |
3003.90.49.320P | Metadona | 7.2 | 0 | 0 | 5 |
3003.90.49.330T | Normetadona | 7.2 | 0 | 0 | 5 |
3003.90.49.340W | Tilidina | 7.2 | 0 | 0 | 5 |
3003.90.49.350Z | Clorhidrato de propoxifeno | 7.2 | 0 | 0 | 5 |
3003.90.49.360C | Dextropropoxifeno | 7.2 | 0 | 0 | 5 |
3003.90.49.390M | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.49.900Q | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.5 | Que contengan productos de las partidas 29.24 a 29.26, sin productos de las subpartidas 3003.90.1 a 3003.90.4 | | | | |
3003.90.51 | Metoclopramida o su clorhidrato; closantel | | | | |
3003.90.51.100W | Metoclopramida o su clorhidrato | 12.6 | 0 | 0 | 5 |
3003.90.51.200B | Closantel | 12.6 | 0 | 0 | 5 |
3003.90.52 | Atenolol; prilocaína o su clorhidrato; talidomida | | | | |
3003.90.52.100D | Atenolol | 12.6 | 0 | 0 | 5 |
3003.90.52.200J | Prilocaína o su clorhidrato | 12.6 | 0 | 0 | 5 |
3003.90.52.300P | Talidomida | 12.6 | 0 | 0 | 5 |
3003.90.53 | Lidocaína o su clorhidrato; flutamida | | | | |
3003.90.53.100L | Lidocaína o su clorhidrato | 12.6 | 0 | 0 | 5 |
3003.90.53.200R | Flutamida | 12.6 | 0 | 0 | 5 |
3003.90.54 | Femproporex | | | | |
3003.90.54.1 | Sicotropos (R. 2017/93 ex-ANA) | | | | |
3003.90.54.110X | Femproporex | 12.6 | 0 | 0 | 5 |
3003.90.55 | Paracetamol; bromoprida | | | | |
3003.90.55.100B | Paracetamol | 12.6 | 0 | 0 | 5 |
3003.90.55.200G | Bromoprida | 12.6 | 0 | 0 | 5 |
3003.90.56 | Amitraz; cipermetrina | | | | |
3003.90.56.100J | Amitraz | 12.6 | 0 | 0 | 5 |
3003.90.56.200P | Cipermetrina | 12.6 | 0 | 0 | 5 |
3003.90.57 | Clorhexidina o sus sales; isetionato de pentamidina | | | | |
3003.90.57.100R | Clorhexidina o sus sales | 12.6 | 0 | 0 | 5 |
3003.90.57.200X | Isetionato de pentamidina | 12.6 | 0 | 0 | 5 |
3003.90.58 | Aminoglutetimida; carmustina; deferoxamina (desferrioxamina B) o sus sales, derivados de estos productos; lomustina | | | | |
3003.90.58.100Z | Carmustina | 0 | 0 | 0 | 5 |
3003.90.58.200E | Lomustina | 0 | 0 | 0 | 5 |
3003.90.58.400Q | Deferoxamina (desferrioxamina B) o sus sales, derivados de estos productos | 0 | 0 | 0 | 5 |
3003.90.58.500W | Aminoglutetimida | 0 | 0 | 0 | 5 |
3003.90.59 | Los demás | | | | |
3003.90.59.1 | Que contengan sicotropos (R.2017/93 ex-ANA) | | | | |
3003.90.59.110K | Glutetimida | 7.2 | 0 | 0 | 5 |
3003.90.59.120N | Sales o ésteres de femproporex | 7.2 | 0 | 0 | 5 |
3003.90.59.130R | Isoaminilo | 7.2 | 0 | 0 | 5 |
3003.90.59.140V | Meprobamato | 7.2 | 0 | 0 | 5 |
3003.90.59.150Y | Etinamato | 7.2 | 0 | 0 | 5 |
3003.90.59.160B | Hexapropimato | 7.2 | 0 | 0 | 5 |
3003.90.59.170E | Mefexamida | 7.2 | 0 | 0 | 5 |
3003.90.59.190L | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.59.2 | Que contengan estupefacientes (R.2017/93 ex-ANA) | | | | |
3003.90.59.210Q | Diampromida | 7.2 | 0 | 0 | 5 |
3003.90.59.220U | 1-Ciano-1,1-difenil-3-dimetilamino-butano (intermediario de la metadona) | 7.2 | 0 | 0 | 5 |
3003.90.59.290R | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.59.900A | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.6 | Que contengan productos de las partidas 29.30 a 29.32, sin productos de las subpartidas 3003.90.1 a 3003.90.5 | | | | |
3003.90.61 | Quercetina | | | | |
3003.90.61.000A | Quercetina | 12.6 | 0 | 0 | 5 |
3003.90.62 | Tiaprida | | | | |
3003.90.62.000H | Tiaprida | 7.2 | 0 | 0 | 5 |
3003.90.63 | Etidronato disódico | | | | |
3003.90.63.000Q | Etidronato disódico | 12.6 | 0 | 0 | 5 |
3003.90.64 | Clorhidrato de amiodarona | | | | |
3003.90.64.000Y | Clorhidrato de amiodarona | 12.6 | 0 | 0 | 5 |
3003.90.65 | Nitrovin; moxidectina | | | | |
3003.90.65.100L | Nitrovin | 12.6 | 0 | 0 | 5 |
3003.90.65.200R | Moxidectina | 12.6 | 0 | 0 | 5 |
3003.90.66 | Ácido clodrónico o su sal disódica; estreptozocina; fotemustina | | | | |
3003.90.66.000N | Ácido clodrónico o su sal disódica; estreptozocina; fotemustina | 0 | 0 | 0 | 5 |
3003.90.67 | Carbocisteína; sulfiram | | | | |
3003.90.67.100B | Carbocisteína | 12.6 | 0 | 0 | 5 |
3003.90.67.200G | Sulfiram | 12.6 | 0 | 0 | 5 |
3003.90.69 | Los demás | | | | |
3003.90.69.1 | Que contenga furoato de dietilestilbestrol | | | | |
3003.90.69.110V | Destinado a medicina veterinaria (R.G. 2146/06 AFIP) | 7.2 | 0 | 0 | 5 |
3003.90.69.190W | Los demás (R.2014/93 ex-ANA) | 7.2 | 0 | 0 | 5 |
3003.90.69.2 | Que contengan sicotropos (R.2017/93 ex-ANA) | | | | |
3003.90.69.21 | Sicotropos Lista I | | | | |
3003.90.69.211C | DMHP | 7.2 | 0 | 0 | 5 |
3003.90.69.212E | MDA | 7.2 | 0 | 0 | 5 |
3003.90.69.213G | MDMA | 7.2 | 0 | 0 | 5 |
3003.90.69.214J | MMDA | 7.2 | 0 | 0 | 5 |
3003.90.69.215L | N-Etil MDA | 7.2 | 0 | 0 | 5 |
3003.90.69.216N | N-Hidroxi MDA | 7.2 | 0 | 0 | 5 |
3003.90.69.217Q | Parahexilo | 7.2 | 0 | 0 | 5 |
3003.90.69.218T | Tetrahidrocanabinoles | 7.2 | 0 | 0 | 5 |
3003.90.69.219V | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.69.29 | Otros sicotropos | | | | |
3003.90.69.291D | Captodiamina | 7.2 | 0 | 0 | 5 |
3003.90.69.292F | Furfenorex | 7.2 | 0 | 0 | 5 |
3003.90.69.293H | Doxepina | 7.2 | 0 | 0 | 5 |
3003.90.69.299W | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.69.300C | Pamidronato disódico | 7.2 | 0 | 0 | 5 |
3003.90.69.900K | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.7 | Que contengan productos de la partida 29.33, sin productos de las subpartidas 3003.90.1 a 3003.90.6 | | | | |
3003.90.71 | Terfenadina; talniflumato; malato ácido de cleboprida; econazol o su nitrato; nitrato de isoconazol; flubendazol; clorhidrato de mepivacaína; trimetoprim; clorhidrato de bupivacaína | | | | |
3003.90.71.100Q | Terfenadina | 12.6 | 0 | 0 | 5 |
3003.90.71.200W | Talniflumato | 12.6 | 0 | 0 | 5 |
3003.90.71.300B | Malato ácido de cleboprida | 12.6 | 0 | 0 | 5 |
3003.90.71.400G | Econazol o su nitrato | 12.6 | 0 | 0 | 5 |
3003.90.71.500M | Nitrato de isoconazol | 12.6 | 0 | 0 | 5 |
3003.90.71.600T | Flubendazol | 12.6 | 0 | 0 | 5 |
3003.90.71.700Y | Clorhidrato de mepivacaína | 12.6 | 0 | 0 | 5 |
3003.90.71.800D | Trimetoprim | 12.6 | 0 | 0 | 5 |
3003.90.71.900J | Clorhidrato de bupivacaína | 12.6 | 0 | 0 | 5 |
3003.90.72 | Clorhidrato de loperamida; fembendazol; ketorolac trometamina; nifedipina; nimodipina; nitrendipina | | | | |
3003.90.72.100Y | Nifedipina | 12.6 | 0 | 0 | 5 |
3003.90.72.200D | Nitrendipina | 12.6 | 0 | 0 | 5 |
3003.90.72.400P | Ketorolac trometamina | 12.6 | 0 | 0 | 5 |
3003.90.72.600A | Fembendazol | 12.6 | 0 | 0 | 5 |
3003.90.72.700F | Clorhidrato de loperamida | 12.6 | 0 | 0 | 5 |
3003.90.72.800L | Nimodipina | 12.6 | 0 | 0 | 5 |
3003.90.73 | Albendazol o su sulfóxido; mebendazol; 6-mercaptopurina; metilsulfato de amezinio; Oxfendazol; praziquantel | | | | |
3003.90.73.100F | Oxfendazol | 12.6 | 0 | 0 | 5 |
3003.90.73.200L | Albendazol o su sulfóxido | 12.6 | 0 | 0 | 5 |
3003.90.73.300R | Mebendazol | 12.6 | 0 | 0 | 5 |
3003.90.73.600H | 6-Mercaptopurina | 12.6 | 0 | 0 | 5 |
3003.90.73.700N | Praziquantel | 12.6 | 0 | 0 | 5 |
3003.90.73.800U | Metilsulfato de amezinio | 12.6 | 0 | 0 | 5 |
3003.90.74 | Alprazolam; bromazepam; clordiazepóxido; clorhidrato de petidina; diazepam; droperidol; mazindol; triazolam | | | | |
3003.90.74.1 | Estupefacientes (R.2017/93 ex-ANA) | | | | |
3003.90.74.110R | Clorhidrato de petidina | 12.6 | 0 | 0 | 5 |
3003.90.74.2 | Sicotropos (R.2017/93 ex-ANA) | | | | |
3003.90.74.210X | Triazolam | 12.6 | 0 | 0 | 5 |
3003.90.74.220A | Alprazolam | 12.6 | 0 | 0 | 5 |
3003.90.74.230D | Diazepam | 12.6 | 0 | 0 | 5 |
3003.90.74.240G | Clorodiazep?xido | 12.6 | 0 | 0 | 5 |
3003.90.74.260N | Bromazepam | 12.6 | 0 | 0 | 5 |
3003.90.74.280V | Mazindol | 12.6 | 0 | 0 | 5 |
3003.90.74.290Y | Droperidol | 12.6 | 0 | 0 | 5 |
3003.90.75 | Benzetimida o su clorhidrato; fenitoína o su sal sódica; isoniazida; pirazinamida | | | | |
3003.90.75.100W | Fenitoína o su sal sódica | 12.6 | 0 | 0 | 5 |
3003.90.75.200B | Benzetimida o su clorhidrato | 12.6 | 0 | 0 | 5 |
3003.90.75.500T | Pirazinamida | 12.6 | 0 | 0 | 5 |
3003.90.75.600Y | Isoniazida | 12.6 | 0 | 0 | 5 |
3003.90.76 | Ácido 2-(2-metil-3-cloroanilino)nicotínico o su sal de lisina; metronidazol o sus sales; nitrato de miconazol | | | | |
3003.90.76.100D | Acido 2-(2-metil-3-cloroanilino)nicotínico o su sal de lisina | 12.6 | 0 | 0 | 5 |
3003.90.76.200J | Metronidazol o sus sales | 12.6 | 0 | 0 | 5 |
3003.90.76.400V | Nitrato de miconazol | 12.6 | 0 | 0 | 5 |
3003.90.77 | Enrofloxacina; maleato de enalapril; maleato de pirilamina; nicarbazina; norfloxacina; sales de piperazina | | | | |
3003.90.77.100L | Nicarbazina | 12.6 | 0 | 0 | 5 |
3003.90.77.200R | Norfloxacina | 12.6 | 0 | 0 | 5 |
3003.90.77.400C | Maleato de enalapril | 12.6 | 0 | 0 | 5 |
3003.90.77.500H | Sales de piperazina | 12.6 | 0 | 0 | 5 |
3003.90.77.600N | Maleato de pirilamina | 12.6 | 0 | 0 | 5 |
3003.90.77.700U | Enrofloxacina | 12.6 | 0 | 0 | 5 |
3003.90.78 | Altretamina; bortezomib; clorhidrato de erlotinib; dacarbacina; disoproxilfumarato de tenofovir; enfuvirtida; fluspirileno; letrozol; lopinavir; mesilato de imatinib; nelfinavir o su mesilato; nevirapine; pemetrexed; saquinavir; sulfato de abacavir; sulfato de atazanavir; sulfato de indinavir; temozolomida; tioguanina; tiopental sodico; tosilato de niraparib; tiretilentiofosfosoforamida; trimetrexato; uracil y tegafur; verteporfin | | | | |
3003.90.78.1 | Sicotropos (R.2017/93 ex-ANA) | | | | |
3003.90.78.110X | Fluspirileno | 0 | 0 | 0 | 5 |
3003.90.78.120A | Tiopental sódico | 0 | 0 | 0 | 5 |
3003.90.78.200Z | Clorhidrato de erlotinib | 0 | 0 | 0 | 5 |
3003.90.78.300E | Trietilentiofosforamida | 0 | 0 | 0 | 5 |
3003.90.78.400K | Tioguanina | 0 | 0 | 0 | 5 |
3003.90.78.600W | Dacarbazina | 0 | 0 | 0 | 5 |
3003.90.78.7 | Trimetrexato; nelfinavir o su mesilato; nevirapine; saquinavir; sulfato de indinavir; letrozol; sulfato de abacavir; lopinavir | | | | |
3003.90.78.720H | Trimetrexato | 0 | 0 | 0 | 5 |
3003.90.78.730L | Nelfinavir o su mesilato | 0 | 0 | 0 | 5 |
3003.90.78.740P | Nevirapine | 0 | 0 | 0 | 5 |
3003.90.78.750T | Saquinavir | 0 | 0 | 0 | 5 |
3003.90.78.760W | Sulfato de indinavir | 0 | 0 | 0 | 5 |
3003.90.78.770Z | Letrozol | 0 | 0 | 0 | 5 |
3003.90.78.780C | Sulfato de abacavir | 0 | 0 | 0 | 5 |
3003.90.78.790F | Lopinavir | 0 | 0 | 0 | 5 |
3003.90.78.8 | Altretamina; bortezomib; disoproxilfumarato de tenofovir; enfuvirtida; mesilato de imatinib; pemetrexed; sulfato de atazanavir; temozolomida; uracil y tegafur; verteporfin | | | | |
3003.90.78.81 | Altretamina; bortezomib; disoproxilfumarato de tenofovir; enfuvirtida; mesilato de imatinib; pemetrexed; sulfato de atazanavir; temozolomida; uracil y tegafur | | | | |
3003.90.78.811M | Altretamina | 0 | 0 | 0 | 5 |
3003.90.78.812P | Bortezomib | 0 | 0 | 0 | 5 |
3003.90.78.813R | Disoproxilfumarato de tenofovir | 0 | 0 | 0 | 5 |
3003.90.78.814U | Enfuvirtida | 0 | 0 | 0 | 5 |
3003.90.78.815W | Mesilato de imatinib | 0 | 0 | 0 | 5 |
3003.90.78.816Y | Pemetrexed | 0 | 0 | 0 | 5 |
3003.90.78.817A | Sulfato de atazanavir | 0 | 0 | 0 | 5 |
3003.90.78.818C | Temozolomida | 0 | 0 | 0 | 5 |
3003.90.78.819E | Uracil y tegafur | 0 | 0 | 0 | 5 |
3003.90.78.820N | Verteporfin | 0 | 0 | 0 | 5 |
3003.90.79 | Los demás | | | | |
3003.90.79.1 | Que contengan sicotropos Lista I (R.2017/93 ex-ANA) | | | | |
3003.90.79.110E | Meclocualona | 7.2 | 0 | 0 | 5 |
3003.90.79.120H | Metacualona | 7.2 | 0 | 0 | 5 |
3003.90.79.130L | Etriptamina | 7.2 | 0 | 0 | 5 |
3003.90.79.140P | Bufotenina | 7.2 | 0 | 0 | 5 |
3003.90.79.150T | PHP o PCPY | 7.2 | 0 | 0 | 5 |
3003.90.79.190F | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.79.2 | Que contengan otros sicotropos, excepto los incluidos en el desarrollo SIM 3003.90.79.5 (R.2017/93 ex-ANA) | | | | |
3003.90.79.21 | Metilfenidato; fenciclidina; secobarbital; zipeprol; pentazocina; alobarbital; amobarbital; aprobarbital; barbital | | | | |
3003.90.79.211M | Metilfenidato | 7.2 | 0 | 0 | 5 |
3003.90.79.212P | Fenciclidina | 7.2 | 0 | 0 | 5 |
3003.90.79.213R | Secobarbital | 7.2 | 0 | 0 | 5 |
3003.90.79.214U | Zipeprol | 7.2 | 0 | 0 | 5 |
3003.90.79.215W | Pentazocina | 7.2 | 0 | 0 | 5 |
3003.90.79.216Y | Alobarbital | 7.2 | 0 | 0 | 5 |
3003.90.79.217A | Amobarbital | 7.2 | 0 | 0 | 5 |
3003.90.79.218C | Aprobarbital | 7.2 | 0 | 0 | 5 |
3003.90.79.219E | Barbital | 7.2 | 0 | 0 | 5 |
3003.90.79.22 | Brallobarbital cálcico; butabarbital sódico; butalbital; butetal; ciclobarbital; fenobarbital; hexobarbital sódico; metarbital; metilfenobarbital | | | | |
3003.90.79.221Q | Brallobarbital cálcico | 7.2 | 0 | 0 | 5 |
3003.90.79.222T | Butabarbital sódico | 7.2 | 0 | 0 | 5 |
3003.90.79.223V | Butalbital | 7.2 | 0 | 0 | 5 |
3003.90.79.224X | Butetal | 7.2 | 0 | 0 | 5 |
3003.90.79.225Z | Ciclobarbital | 7.2 | 0 | 0 | 5 |
3003.90.79.226B | Fenobarbital | 7.2 | 0 | 0 | 5 |
3003.90.79.227D | Hexobarbital sódico | 7.2 | 0 | 0 | 5 |
3003.90.79.228F | Metarbital | 7.2 | 0 | 0 | 5 |
3003.90.79.229H | Metilfenobarbital | 7.2 | 0 | 0 | 5 |
3003.90.79.23 | Pentobarbital; proxibarbal; ipronal o axeen; secbutabarbital; tiamilal sódico; vinilbital; flunitrazepam; midazolam; penfluoridol | | | | |
3003.90.79.231U | Pentobarbital | 7.2 | 0 | 0 | 5 |
3003.90.79.232W | Proxibarbal, ipronal o axeen | 7.2 | 0 | 0 | 5 |
3003.90.79.233Y | Secbutabarbital | 7.2 | 0 | 0 | 5 |
3003.90.79.234A | Tiamilal sódico | 7.2 | 0 | 0 | 5 |
3003.90.79.235C | Vinilvital | 7.2 | 0 | 0 | 5 |
3003.90.79.236E | Flunitrazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.237G | Midazolam | 7.2 | 0 | 0 | 5 |
3003.90.79.238J | Penfluoridol | 7.2 | 0 | 0 | 5 |
3003.90.79.24 | Trifluperidol; haloperidol; nialamida; sales o esteres de droperidol; clorhidrato de azaclinolol; bemperidol; pimozida; pipradol; nomifensin | | | | |
3003.90.79.241X | Trifluperidol | 7.2 | 0 | 0 | 5 |
3003.90.79.242Z | Haloperidol | 7.2 | 0 | 0 | 5 |
3003.90.79.243B | Nialamida | 7.2 | 0 | 0 | 5 |
3003.90.79.244D | Sales o esteres de droperidol | 7.2 | 0 | 0 | 5 |
3003.90.79.245F | Clorhidrato de azaclinolol | 7.2 | 0 | 0 | 5 |
3003.90.79.246H | Bemperidol | 7.2 | 0 | 0 | 5 |
3003.90.79.247K | Pimozida | 7.2 | 0 | 0 | 5 |
3003.90.79.248M | Pipradol | 7.2 | 0 | 0 | 5 |
3003.90.79.249P | Nomifensin | 7.2 | 0 | 0 | 5 |
3003.90.79.25 | Clozapina; etodroxicina; clorhidrato de hidroxicina; loprazolam; opipramol; trazodona; metiprilona; sales o ésteres de bromazepam; clorhidrato de clordiazepóxido | | | | |
3003.90.79.251A | Clozapina | 7.2 | 0 | 0 | 5 |
3003.90.79.252C | Etodroxicina | 7.2 | 0 | 0 | 5 |
3003.90.79.253E | Clorhidrato de hidroxicina | 7.2 | 0 | 0 | 5 |
3003.90.79.254G | Loprazolam | 7.2 | 0 | 0 | 5 |
3003.90.79.255J | Opipramol | 7.2 | 0 | 0 | 5 |
3003.90.79.256L | Trazodona | 7.2 | 0 | 0 | 5 |
3003.90.79.257N | Metiprilona | 7.2 | 0 | 0 | 5 |
3003.90.79.258Q | Sales o esteres de bromazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.259T | Clorhidrato de clordiazepóxido | 7.2 | 0 | 0 | 5 |
3003.90.79.26 | Sales o ésteres de diazepam; oxazepam, sus sales o sus ésteres; camazepam; clobazam; clonazepam; clorazepato dipotásico; clorimipramina; delorazepam; desipramina | | | | |
3003.90.79.261D | Sales o esteres de Diazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.262F | Oxazepam, sus sales o sus esteres | 7.2 | 0 | 0 | 5 |
3003.90.79.263H | Camazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.264K | Clobazam | 7.2 | 0 | 0 | 5 |
3003.90.79.265M | Clonazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.266P | Clorazepato dipot?sico | 7.2 | 0 | 0 | 5 |
3003.90.79.267R | Clorimipramina | 7.2 | 0 | 0 | 5 |
3003.90.79.268U | Delorazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.269W | Desipramina | 7.2 | 0 | 0 | 5 |
3003.90.79.27 | Dibenzepina; fludiazepam; flurazepam; halazepam; imipramina; loflazepato de etilo; lorazepam; lormetazepam; medazepam | | | | |
3003.90.79.271G | Dibenzepina | 7.2 | 0 | 0 | 5 |
3003.90.79.272J | Fludiazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.273L | Flurazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.274N | Halazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.275Q | Imipramina | 7.2 | 0 | 0 | 5 |
3003.90.79.276T | Loflazepato de etilo | 7.2 | 0 | 0 | 5 |
3003.90.79.277V | Lorazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.278X | Lormetazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.279Z | Medazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.28 | N-Desmetildiazepam o nordazepam; nimetazepam; nitrazepam; nitrazepato de potasio; pinazepam; prazepam; sulazepam; temazepam; tetrazepam | | | | |
3003.90.79.281K | N-Desmetildiazepam o nordazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.282M | Nimetazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.283P | Nitrazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.284R | Nitrazepato de potasio | 7.2 | 0 | 0 | 5 |
3003.90.79.285U | Pinazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.286W | Prazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.287Y | Sulazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.288A | Temazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.289C | Tetrazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.29 | Los demás | | | | |
3003.90.79.291N | Trimipramina | 7.2 | 0 | 0 | 5 |
3003.90.79.292Q | Oxipertina | 7.2 | 0 | 0 | 5 |
3003.90.79.293T | Piracetam | 7.2 | 0 | 0 | 5 |
3003.90.79.294V | Pirovalerona | 7.2 | 0 | 0 | 5 |
3003.90.79.295X | Prolintano | 7.2 | 0 | 0 | 5 |
3003.90.79.296Z | Quazepam | 7.2 | 0 | 0 | 5 |
3003.90.79.297B | Estazolam | 7.2 | 0 | 0 | 5 |
3003.90.79.299F | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.79.3 | Que contengan estupefacientes Lista IV (R.2017/93 ex-ANA) | | | | |
3003.90.79.310Q | MPPP | 7.2 | 0 | 0 | 5 |
3003.90.79.320U | PEPAP | 7.2 | 0 | 0 | 5 |
3003.90.79.330X | Metilfentanilo | 7.2 | 0 | 0 | 5 |
3003.90.79.340A | Acetil-alfa-metilfentanilo | 7.2 | 0 | 0 | 5 |
3003.90.79.350D | alfa-Metilfentanilo | 7.2 | 0 | 0 | 5 |
3003.90.79.360G | Cetobemidona | 7.2 | 0 | 0 | 5 |
3003.90.79.370K | beta-Hidroxifentanilo | 7.2 | 0 | 0 | 5 |
3003.90.79.39 | Los demás | | | | |
3003.90.79.391U | beta-Hidroxi-3-metilfentanilo | 7.2 | 0 | 0 | 5 |
3003.90.79.392W | para-Fluorofentanilo | 7.2 | 0 | 0 | 5 |
3003.90.79.399L | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.79.4 | Que contengan otros estupefacientes (R.2017/93 ex-ANA) | | | | |
3003.90.79.41 | Difenoxina; etoxeridina; fenoperidina; intermediario C de la petidina; clorhidrato de difenoxilato; anileridina; benzetidina; beta-meprodina; beta-prodina | | | | |
3003.90.79.411Y | Difenoxina | 7.2 | 0 | 0 | 5 |
3003.90.79.412A | Etoxeridina | 7.2 | 0 | 0 | 5 |
3003.90.79.413C | Fenoperidina | 7.2 | 0 | 0 | 5 |
3003.90.79.414E | Intermediario C de la petidina | 7.2 | 0 | 0 | 5 |
3003.90.79.415G | Clorhidrato de difenoxilato | 7.2 | 0 | 0 | 5 |
3003.90.79.416J | Anileridina | 7.2 | 0 | 0 | 5 |
3003.90.79.417L | Benzetidina | 7.2 | 0 | 0 | 5 |
3003.90.79.418N | beta-meprodina | 7.2 | 0 | 0 | 5 |
3003.90.79.419Q | beta-prodina | 7.2 | 0 | 0 | 5 |
3003.90.79.42 | Difenoxilato; hidroxipetidina; petidina y sus sales, excepto el clorhidrato; piminodina; properidina; trimeperidina; dipipanona; intermediario B de la petidina; becitramida | | | | |
3003.90.79.421B | Difenoxilato | 7.2 | 0 | 0 | 5 |
3003.90.79.422D | Hidroxipetidina | 7.2 | 0 | 0 | 5 |
3003.90.79.423F | Petidina y sus sales, excepto el clorhidrato | 7.2 | 0 | 0 | 5 |
3003.90.79.424H | Piminodina | 7.2 | 0 | 0 | 5 |
3003.90.79.425K | Properidina | 7.2 | 0 | 0 | 5 |
3003.90.79.426M | Trimeperidina | 7.2 | 0 | 0 | 5 |
3003.90.79.427P | Dipipanona | 7.2 | 0 | 0 | 5 |
3003.90.79.428R | Intermediario B de la petidina | 7.2 | 0 | 0 | 5 |
3003.90.79.429U | Becitramida | 7.2 | 0 | 0 | 5 |
3003.90.79.43 | Fenampromida; piritramida; intermediario A de la petidina; alfa-meprodina; alfa-prodina; alfentanil; alil prodina; fentanil; norpipanona | | | | |
3003.90.79.431E | Fenampromida | 7.2 | 0 | 0 | 5 |
3003.90.79.432G | Piritramida | 7.2 | 0 | 0 | 5 |
3003.90.79.433J | Intermediario A de la petidina | 7.2 | 0 | 0 | 5 |
3003.90.79.434L | alfa-Meprodina | 7.2 | 0 | 0 | 5 |
3003.90.79.435N | alfa-Prodina | 7.2 | 0 | 0 | 5 |
3003.90.79.436Q | Alfentanil | 7.2 | 0 | 0 | 5 |
3003.90.79.437T | Alil prodina | 7.2 | 0 | 0 | 5 |
3003.90.79.438V | Fentanil | 7.2 | 0 | 0 | 5 |
3003.90.79.439X | Norpipanona | 7.2 | 0 | 0 | 5 |
3003.90.79.44 | Drotebanol; fenazocina; fenomorfan; levofenacilmorfan; levometorfan; levorfanol; metazocina; norlevorfanol; racemetorfan | | | | |
3003.90.79.441H | Drotebanol | 7.2 | 0 | 0 | 5 |
3003.90.79.442K | Fenazocina | 7.2 | 0 | 0 | 5 |
3003.90.79.443M | Fenomorfan | 7.2 | 0 | 0 | 5 |
3003.90.79.444P | Levofenacilmorfan | 7.2 | 0 | 0 | 5 |
3003.90.79.445R | Levometorfan | 7.2 | 0 | 0 | 5 |
3003.90.79.446U | Levorfanol | 7.2 | 0 | 0 | 5 |
3003.90.79.447W | Metazocina | 7.2 | 0 | 0 | 5 |
3003.90.79.448Y | Norlevorfanol | 7.2 | 0 | 0 | 5 |
3003.90.79.449A | Racemetorfan | 7.2 | 0 | 0 | 5 |
3003.90.79.45 | Racemorfan; proheptazina; clonitaceno; etonitaceno; propiramo | | | | |
3003.90.79.451L | Racemorfan | 7.2 | 0 | 0 | 5 |
3003.90.79.452N | Proheptazina | 7.2 | 0 | 0 | 5 |
3003.90.79.453Q | Clonitaceno | 7.2 | 0 | 0 | 5 |
3003.90.79.454T | Etonitaceno | 7.2 | 0 | 0 | 5 |
3003.90.79.455V | Propiramo | 7.2 | 0 | 0 | 5 |
3003.90.79.490X | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.79.5 | Otros, que contengan otros sicotropos (R. 2017/93 ex-ANA) | | | | |
3003.90.79.510B | Sales o esteres de alprazolam | 7.2 | 0 | 0 | 5 |
3003.90.79.520E | Sales de esteres de triazolam | 7.2 | 0 | 0 | 5 |
3003.90.79.530H | Sales o esteres de mazindol | 7.2 | 0 | 0 | 5 |
3003.90.79.540L | Sales o esteres de fluspirileno | 7.2 | 0 | 0 | 5 |
3003.90.79.600D | Ácido zoledr?nico | 7.2 | 0 | 0 | 5 |
3003.90.79.9 | Los demás | | | | |
3003.90.79.91 | Para medicina veterinaria | | | | |
3003.90.79.911A | Que contengan carbadox (R.57/16 SENASA) | 7.2 | 0 | 0 | 5 |
3003.90.79.919T | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.79.990Z | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.8 | Que contengan productos de las partidas 29.34, 29.35 y 29.38, sin productos de las subpartidas 3003.90.1 a 3003.90.7 | | | | |
3003.90.81 | Levamisol o sus sales; tetramisol | | | | |
3003.90.81.100A | Levamisol o sus sales | 7.2 | 0 | 0 | 5 |
3003.90.81.200F | Tetramisol | 7.2 | 0 | 0 | 5 |
3003.90.82 | Sulfadiazina o su sal sódica; sulfametoxazol | | | | |
3003.90.82.100H | Sulfadiazina o su sal sódica | 12.6 | 0 | 0 | 5 |
3003.90.82.300U | Sulfametoxazol | 12.6 | 0 | 0 | 5 |
3003.90.83 | Cloxazolam; ketazolam; piroxicam; tenoxicam | | | | |
3003.90.83.1 | Sicotropos (R.2017/93 ex-ANA) | | | | |
3003.90.83.110U | Ketazolam | 12.6 | 0 | 0 | 5 |
3003.90.83.130A | Cloxazolam | 12.6 | 0 | 0 | 5 |
3003.90.83.300B | Tenoxicam | 12.6 | 0 | 0 | 5 |
3003.90.83.400G | Piroxicam | 12.6 | 0 | 0 | 5 |
3003.90.84 | Ftalilsulfatiazol; inosina | | | | |
3003.90.84.100Y | Ftalilsulfatiazol | 12.6 | 0 | 0 | 5 |
3003.90.84.300J | Inosina | 12.6 | 0 | 0 | 5 |
3003.90.85 | Enantato de flufenazina; prometazina; gliburida; rutósido; deslanósido | | | | |
3003.90.85.1 | Sicotropos (R. 2017/93 ex-ANA) | | | | |
3003.90.85.110J | Enantato de Flufenazina | 12.6 | 0 | 0 | 5 |
3003.90.85.120M | Prometazina | 12.6 | 0 | 0 | 5 |
3003.90.85.200L | Gliburida | 12.6 | 0 | 0 | 5 |
3003.90.85.300R | Rutósido | 12.6 | 0 | 0 | 5 |
3003.90.85.400X | Deslanósido | 12.6 | 0 | 0 | 5 |
3003.90.86 | Clortalidona; furosemida | | | | |
3003.90.86.100N | Furosemida | 12.6 | 0 | 0 | 5 |
3003.90.86.200U | Clortalidona | 12.6 | 0 | 0 | 5 |
3003.90.87 | Clorhidrato de tizanidina; furazolidona; ketoconazol | | | | |
3003.90.87.100W | Clorhidrato de tizanidina | 12.6 | 0 | 0 | 5 |
3003.90.87.300G | Furazolidona | 12.6 | 0 | 0 | 5 |
3003.90.87.400M | Ketoconazol | 12.6 | 0 | 0 | 5 |
3003.90.88 | Amprenavir; aprepitanto; delavirdina o su mesilato; efavirenz; emtricitabina; etoposido; everolimus; fosamprenavir calcico; fosfato de fludarabina; gemcitabina o su clorhidrato; raltitrexida; ritonavir; sirolimus; tacrolimus; temsirolimus; teniposido; tipranavir | | | | |
3003.90.88.100D | Temsirolimus | 0 | 0 | 0 | 5 |
3003.90.88.300P | Ritonavir | 0 | 0 | 0 | 5 |
3003.90.88.400V | Tenipósido | 0 | 0 | 0 | 5 |
3003.90.88.500A | Fosfato de fludarabina | 0 | 0 | 0 | 5 |
3003.90.88.600F | Gemcitabina o su clorhidrato | 0 | 0 | 0 | 5 |
3003.90.88.700L | Efavirenz | 0 | 0 | 0 | 5 |
3003.90.88.8 | Amprenavir; aprepitanto; delavirdina o su mesilato; emtricitabina; etopósido; everolimus; fosamprenavir cálcico; raltitrexida; sirolimus; tacrolimus | | | | |
3003.90.88.810V | Amprenavir | 0 | 0 | 0 | 5 |
3003.90.88.820Y | Aprepitanto | 0 | 0 | 0 | 5 |
3003.90.88.830B | Delavirdina o su mesilato | 0 | 0 | 0 | 5 |
3003.90.88.840E | Emtricitabina | 0 | 0 | 0 | 5 |
3003.90.88.850H | Fosamprenavir cálcico | 0 | 0 | 0 | 5 |
3003.90.88.860L | Raltitrexida | 0 | 0 | 0 | 5 |
3003.90.88.870P | Etopósido | 0 | 0 | 0 | 5 |
3003.90.88.880T | Tacrolimus | 0 | 0 | 0 | 5 |
3003.90.88.89 | Everolimus; sirolimus; tipranavir | | | | |
3003.90.88.891Y | Everolimus | 0 | 0 | 0 | 5 |
3003.90.88.892A | Sirolimus | 0 | 0 | 0 | 5 |
3003.90.88.893C | Tipranavir | 0 | 0 | 0 | 5 |
3003.90.89 | Los demás | | | | |
3003.90.89.1 | Que contengan sicotropos Lista I (R. 2017/93 ex-ANA) | | | | |
3003.90.89.110P | TCP | 7.2 | 0 | 0 | 5 |
3003.90.89.120T | Metilaminorex | 7.2 | 0 | 0 | 5 |
3003.90.89.190Q | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.89.2 | Que contengan otros sicotropos (R. 2017/93 ex-ANA) | | | | |
3003.90.89.21 | Fendimetrazina; fenmetrazina; clometiazol; acepromazina; aceprometazina; alimenazina; butirilperazina; clormezanona, sus sales o sus esteres; clorhidrato de clorpromazina | | | | |
3003.90.89.211X | Fendimetrazina | 7.2 | 0 | 0 | 5 |
3003.90.89.212Z | Fenmetrazina | 7.2 | 0 | 0 | 5 |
3003.90.89.213B | Clometiazol | 7.2 | 0 | 0 | 5 |
3003.90.89.214D | Acepromazina | 7.2 | 0 | 0 | 5 |
3003.90.89.215F | Aceprometazina | 7.2 | 0 | 0 | 5 |
3003.90.89.216H | Alimenazina | 7.2 | 0 | 0 | 5 |
3003.90.89.217K | Butirilperazina | 7.2 | 0 | 0 | 5 |
3003.90.89.218M | Clormezanona sus sales o sus esteres | 7.2 | 0 | 0 | 5 |
3003.90.89.219P | Clorhidrato de clorpromazina | 7.2 | 0 | 0 | 5 |
3003.90.89.22 | Dixirazina; clorhidrato de flufenazina; homofenazina; maleato de levomepromazina; metopromazina; perfenazina; piperacetazina; edisilato de proclorperazina; maleato de proclorperazina | | | | |
3003.90.89.221A | Dixirazina | 7.2 | 0 | 0 | 5 |
3003.90.89.222C | Clorhidrato de flufenazina | 7.2 | 0 | 0 | 5 |
3003.90.89.223E | Homofenazina | 7.2 | 0 | 0 | 5 |
3003.90.89.224G | Maleato de levomepromazina | 7.2 | 0 | 0 | 5 |
3003.90.89.225J | Metopromazina | 7.2 | 0 | 0 | 5 |
3003.90.89.226L | Perfenazina | 7.2 | 0 | 0 | 5 |
3003.90.89.227N | Piperacetazina | 7.2 | 0 | 0 | 5 |
3003.90.89.228Q | Edisilato de proclorperazina | 7.2 | 0 | 0 | 5 |
3003.90.89.229T | Maleato de proclorperazina | 7.2 | 0 | 0 | 5 |
3003.90.89.23 | Clorhidrato de promazina; clorhidrato de prometazina; propericiazina; clorhidrato de tioridazina; clorhidrato de trifluoperazina; clorhidrato de triflupromazina; clorhidrato de tripropazato; sales o esteres de ketazolam; mesocarbo | | | | |
3003.90.89.231D | Clorhidrato de promazina | 7.2 | 0 | 0 | 5 |
3003.90.89.232F | Clorhidrato de prometazina | 7.2 | 0 | 0 | 5 |
3003.90.89.233H | Propericiazina | 7.2 | 0 | 0 | 5 |
3003.90.89.234K | Clorhidrato de tioridazina | 7.2 | 0 | 0 | 5 |
3003.90.89.235M | Clorhidrato de trifluoperazina | 7.2 | 0 | 0 | 5 |
3003.90.89.236P | Clorhidrato de triflupromazina | 7.2 | 0 | 0 | 5 |
3003.90.89.237R | Clorhidrato de tripropazato | 7.2 | 0 | 0 | 5 |
3003.90.89.238U | Sales o esteres de ketazolam | 7.2 | 0 | 0 | 5 |
3003.90.89.239W | Mesocarbo | 7.2 | 0 | 0 | 5 |
3003.90.89.24 | Aminorex; isocarboxiazida; brotizolam; clotiapina; clotiazepam; clorprotixeno; etifoxina; haloxazolam | | | | |
3003.90.89.241G | Aminorex | 7.2 | 0 | 0 | 5 |
3003.90.89.242J | Isocarboxiazida | 7.2 | 0 | 0 | 5 |
3003.90.89.243L | Brotizolam | 7.2 | 0 | 0 | 5 |
3003.90.89.244N | Clotiapina | 7.2 | 0 | 0 | 5 |
3003.90.89.245Q | Clotiazepam | 7.2 | 0 | 0 | 5 |
3003.90.89.246T | Clorprotixeno | 7.2 | 0 | 0 | 5 |
3003.90.89.248X | Etifoxina | 7.2 | 0 | 0 | 5 |
3003.90.89.249Z | Haloxazolam | 7.2 | 0 | 0 | 5 |
3003.90.89.25 | Loxapina; oxazolam; pemolina y sus sales; succinato de loxapina; ácido 2-metil-3-morfolino-1,1- difenil-propano-carboxílico (Intermediario de la moramida); sulpirida, sus sales o sus esteres; pipotiazina; tioperazina; mesilato de tioproperazina | | | | |
3003.90.89.251K | Loxapina | 7.2 | 0 | 0 | 5 |
3003.90.89.252M | Oxazolam | 7.2 | 0 | 0 | 5 |
3003.90.89.253P | Pemolina y sus sales | 7.2 | 0 | 0 | 5 |
3003.90.89.254R | Succinato de loxapina | 7.2 | 0 | 0 | 5 |
3003.90.89.255U | Ácido 2-metil-3-morfolino-1,1-difenil- propano-carboxílico (intermediario de la moramida) | 7.2 | 0 | 0 | 5 |
3003.90.89.256W | Sulpirida, sus sales o sus esteres | 7.2 | 0 | 0 | 5 |
3003.90.89.257Y | Pipotiazina | 7.2 | 0 | 0 | 5 |
3003.90.89.258A | Tioperazina | 7.2 | 0 | 0 | 5 |
3003.90.89.259C | Mesilato de tioproperazina | 7.2 | 0 | 0 | 5 |
3003.90.89.260L | Tiotixeno | 7.2 | 0 | 0 | 5 |
3003.90.89.290W | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.89.3 | Que contengan estupefacientes Lista IV (R. 2017/93 ex-ANA) | | | | |
3003.90.89.310A | alfa-Metiltiofentanilo | 7.2 | 0 | 0 | 5 |
3003.90.89.320D | Metiltiofentanilo | 7.2 | 0 | 0 | 5 |
3003.90.89.330G | Tiofentanilo | 7.2 | 0 | 0 | 5 |
3003.90.89.390B | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.89.4 | Que contengan otros estupefacientes (R. 2017/93 ex-ANA) | | | | |
3003.90.89.41 | Dietiltiambuteno; dimetiltiambuteno; etilmetiltiambuteno; sufentanil; butirato de dioxafetilo; dextromoramida; fenadoxona; levomoramida; morferidina | | | | |
3003.90.89.411H | Dietiltiambuteno | 7.2 | 0 | 0 | 5 |
3003.90.89.412K | Dimetiltiambuteno | 7.2 | 0 | 0 | 5 |
3003.90.89.413M | Etilmetiltiambuteno | 7.2 | 0 | 0 | 5 |
3003.90.89.414P | Sufentanil | 7.2 | 0 | 0 | 5 |
3003.90.89.415R | Butirato de dioxafetilo | 7.2 | 0 | 0 | 5 |
3003.90.89.416U | Dextromoramida | 7.2 | 0 | 0 | 5 |
3003.90.89.417W | Fenadoxona | 7.2 | 0 | 0 | 5 |
3003.90.89.418Y | Levomoramida | 7.2 | 0 | 0 | 5 |
3003.90.89.419A | Morferidina | 7.2 | 0 | 0 | 5 |
3003.90.89.42 | Racemoramida; furetidina | | | | |
3003.90.89.421L | Racemoramida | 7.2 | 0 | 0 | 5 |
3003.90.89.422N | Furetidina | 7.2 | 0 | 0 | 5 |
3003.90.89.490G | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.89.9 | Los demás | | | | |
3003.90.89.920L | Zidovudina | 7.2 | 0 | 0 | 5 |
3003.90.89.930P | Lamivudina | 7.2 | 0 | 0 | 5 |
3003.90.89.940T | Stavudina | 7.2 | 0 | 0 | 5 |
3003.90.89.950W | Didanosina | 7.2 | 0 | 0 | 5 |
3003.90.89.960Z | Dideoxiadenosina | 7.2 | 0 | 0 | 5 |
3003.90.89.970C | Zalcitavina | 7.2 | 0 | 0 | 5 |
3003.90.89.990J | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.9 | Los demás | | | | |
3003.90.91 | Extracto de polen | | | | |
3003.90.91.000E | Extracto de polen | 7.2 | 0 | 0 | 5 |
3003.90.92 | Crisarobina; disofenol | | | | |
3003.90.92.100T | Disofenol | 12.6 | 0 | 0 | 5 |
3003.90.92.200Y | Crisarobina | 12.6 | 0 | 0 | 5 |
3003.90.93 | Diclofenac resinato | | | | |
3003.90.93.000V | Diclofenac resinato | 12.6 | 0 | 0 | 5 |
3003.90.94 | Silimarina | | | | |
3003.90.94.000C | Silimarina | 7.2 | 0 | 0 | 5 |
3003.90.95 | Busulfano; dexormaplatino; dietilestilbestrol o su dipropionato; enloplatino; iproplatino; lobaplatino; miboplatino; miltefosina; mitotano; ormaplatino; procarbazina o su clorhidrato; propofol; sebriplatino; zeniplatino | | | | |
3003.90.95.100Q | Propofol | 0 | 0 | 0 | 5 |
3003.90.95.200W | Busulfano | 0 | 0 | 0 | 5 |
3003.90.95.300B | Mitotano | 0 | 0 | 0 | 5 |
3003.90.95.400G | Dexormaplatino; enloplatino; iproplatino; lobaplatino; miboplatino;ormaplatino; sebriplatino; zeniplatino | 0 | 0 | 0 | 5 |
3003.90.95.5 | Dietilestilbestrol o su dipropionato | | | | |
3003.90.95.510Q | Destinado a medicina veterinaria (R.G. 2146/06 AFIP) | 0 | 0 | 0 | 5 |
3003.90.95.590R | Los demás (R. 2014/93 ex ANA) | 0 | 0 | 0 | 5 |
3003.90.95.6 | Miltefosina; procarbazina o su clorhidrato | | | | |
3003.90.95.610W | Miltefosina | 0 | 0 | 0 | 5 |
3003.90.95.620Z | Procarbazina o su clorhidrato | 0 | 0 | 0 | 5 |
3003.90.96 | Complejo hierro dextrano | | | | |
3003.90.96.000T | Complejo hierro dextrano | 12.6 | 0 | 0 | 5 |
3003.90.97 | Sevoflurano | | | | |
3003.90.97.000A | Sevoflurano | 12.6 | 0 | 0 | 5 |
3003.90.99 | Los demás | | | | |
3003.90.99.1 | Que contengan sicotropos (R.2017/93 ex-ANA) | | | | |
3003.90.99.11 | Metilpentinol; etclorvinol; alcohol tribromoetílico; pentaeritritol diclorhidrina; fenpentadiol; mefenesina; fenelzina; iproclozida; noxiptilina | | | | |
3003.90.99.111B | Metilpentinol | 7.2 | 0 | 0 | 5 |
3003.90.99.112D | Etclorvinol | 7.2 | 0 | 0 | 5 |
3003.90.99.113F | Alcohol tribromoet?lico | 7.2 | 0 | 0 | 5 |
3003.90.99.114H | Pentaeritritol diclorhidrina | 7.2 | 0 | 0 | 5 |
3003.90.99.115K | Fenpentadiol | 7.2 | 0 | 0 | 5 |
3003.90.99.116M | Mefenesina | 7.2 | 0 | 0 | 5 |
3003.90.99.117P | Fenelzina | 7.2 | 0 | 0 | 5 |
3003.90.99.118R | Iproclozida | 7.2 | 0 | 0 | 5 |
3003.90.99.119U | Noxiptilina | 7.2 | 0 | 0 | 5 |
3003.90.99.190A | Los demás | 7.2 | 0 | 0 | 5 |
3003.90.99.2 | Que contengan estupefacientes (R. 2017/93 ex-ANA) | | | | |
3003.90.99.210E | Estupefacientes Lista IV | 7.2 | 0 | 0 | 5 |
3003.90.99.290F | Otros estupefacientes | 7.2 | 0 | 0 | 5 |
3003.90.99.3 | Que contengan palmitato de dietilestilbestrol, o que contengan hexestrol, su dipropionato o su diacetato, o diacetato de dienoestrol | | | | |
3003.90.99.310K | Destinado a medicina veterinaria (R.G. 2146/06 AFIP) | 7.2 | 0 | 0 | 5 |
3003.90.99.390L | Los demás (R.2014/93 ex-ANA) | 7.2 | 0 | 0 | 5 |
3003.90.99.4 | Antiparasitarios usados en medicina veterinaria | | | | |
3003.90.99.410Q | Que contengan lindano (R.G. 2146/06 AFIP) | 7.2 | 0 | 0 | 5 |
3003.90.99.490R | Los demás (R.2012/93 ex-ANA) | 7.2 | 0 | 0 | 5 |
3003.90.99.900P | Los demás | 7.2 | 0 | 0 | 5 |